866-997-4948(US-Canada Toll Free)

BTG plc (BTG) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 42 Pages


BTG plc (BTG) is an international specialist healthcare company. The company operates in three areas, namely, interventional medicine; specialty pharmaceuticals; and licensing and biotechnology. BTG offers products for the treatment of cancer, snakebites, liver, prostate tumours and medicines for heart diseases. The company has various under development products through partnered programmes. It commercializes products through different brands such as CroFab, Voraxaze, DigiFab, LC Bead, Bead Block, DC Bead and Zytiga. The company offers its products through its direct network in the US and sells through distribution partners in other countries. BTG manufactures ovine polyclonal antibodies, embolisation, brachytherapy products, drug-eluting beads. The company along with its subsidiaries and partnership agreements operates in the US, the UK, Japan, Australia and Germany. BTG is headquartered in London, the UK.

This report is a source for data, analysis and actionable intelligence on the BTG plc portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4

BTG plc - Business Description 5

Key Facts 6
BTG plc - Major Products and Services 7
BTG plc Pipeline Products by Equipment Type 8
BTG plc Pipeline Products by Development Stage 10
BTG plc Pipeline Products by Therapy Area 12
BTG plc Pipeline Products by Trial Phase 14
BTG plc Pipeline Products by Milestone Summary 16
CellBead - Neuro 18
CellBead - Neuro Product Status 18
CellBead - Neuro Product Description 18
CellBead - Neuro Product Milestone 18
CellBead - Neuro Clinical Trial 20
PARAGON Bead 21
PARAGON Bead Product Status 21
PARAGON Bead Product Description 21
PARAGON Bead Product Milestone 21
PARAGON Bead Clinical Trial 22
PARAGON Bead Product Patent Details 31
BTG plc - Key Competitors 33
BTG plc - Key Employees 34
BTG plc - Key Employee Biographies 35
BTG plc - Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 37
BTG plc, Recent Developments 37
Nov 08, 2012: BTG Reports Revenue Of 143.4m In H1 Fiscal 2013 37
May 21, 2012: BTG Reports Revenue Of 197m In Fiscal 2012 39
Feb 14, 2012: BTG Announces Directorate Change Amendment 40
Nov 17, 2011: BTG Reports Revenue Of 110.6m In H1 Fiscal 2012 40
May 25, 2011: BTG Reports Total Revenue Of 111.4m For Fiscal 2011 41

Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Table


BTG plc, Key Facts 1
BTG plc Key Pipeline Products by Equipment Type 1
BTG plc Key Pipeline Products by Therapy Area 1
BTG plc Key Pipeline Products by Development Stage 1
BTG plc Key Pipeline Products by Trial Phase 1
BTG plc, Key Facts 6
BTG plc, Major Products and Services 7
BTG plc Number of Pipeline Products by Equipment Type 8
BTG plc Pipeline Products by Equipment Type 9
BTG plc Number of Pipeline Products by Development Stage 10
BTG plc Pipeline Products by Development Stage 11
BTG plc Number of Pipeline Products by Therapy Area 12
BTG plc Pipeline Products by Therapy Area 13
BTG plc Number of Pipeline Products by Trial Phase 14
BTG plc Pipeline Products by Trial Phase 15
BTG plc Number of Pipeline Products By Milestone Summary 16
BTG plc Pipeline Products by Milestone Summary 17
CellBead - Neuro - Product Status 18
CellBead - Neuro - Product Description 18
CellBead - Neuro - Product Milestone 18
CellBead - Neuro - A Prospective study on the Treatment of Stroke Patient with Stem Cell Therapy Product 20
PARAGON Bead - Product Status 21
PARAGON Bead - Product Description 21
PARAGON Bead - Product Milestone 21
PARAGON Bead - Evaluation of the PARAGON Bead in the treatment of hepatic colorectal metastases 22
PARAGON Bead - A Single Arm Phase II Study of Neoadjuvant Therapy Using Irinotecan Bead in Patients With Resectable Liver Metastases From Colorectal Cancer 23
PARAGON Bead - Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Concomitant Systemic Oxaliplatin, Fluorouracil and Leucovorin Chemotherapy, and Anti-Angiogenic Therapy 25
PARAGON Bead - Feasibility and Prospective Randomized Study of Transarterial Chemoembolization Using Irinotecan Bead in Combination With Second Line Chemotherapy in the Treatment of Patients With Unresectable Metastatic Colorectal Cancer 27
PARAGON Bead - Comparative, Prospective, Open-labeled, Randomized Phase II Study of Cisplatin/Gemcitabine in Combination With Irinotecan-loaded LC Bead Versus Cisplatin/Gemcitabine Alone in the Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma 30
PARAGON Bead - Patent Details1 31
PARAGON Bead - Patent Details2 31
BTG plc, Key Employees 34
BTG plc, Key Employee Biographies 35
BTG plc, Subsidiaries 36

List of Chart


BTG plc Pipeline Products by Equipment Type 8
BTG plc Pipeline Products by Development Stage 10
BTG plc Pipeline Products by Therapy Area 12
BTG plc Pipeline Products by Trial Phase 14
BTG plc Pipeline Products by Milestone Summary 16

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *